Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis

B E Peace1, M J Hughes, S J Degen

  • 1Division of Developmental Biology, Children's Hospital Research Foundation, 3333 Burnet Avenue, Cincinnati, OH 45229, USA.

Oncogene
|October 11, 2001
PubMed

Insights

The study found that the receptor tyrosine kinase Ron, when mutated or overexpressed, drives tumor formation and metastasis. Ron acts as an aggressive oncogene, promoting cell proliferation and tumor growth in vivo.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • The receptor tyrosine kinase Ron shares similarities with oncogenes like Met.
  • Ron signaling regulates critical cellular processes such as proliferation and invasion.
  • Its role in tumorigenesis was previously hypothesized but not fully elucidated.

Purpose of the Study:

  • To investigate the oncogenic potential of wild-type and mutated mouse Ron.
  • To determine if Ron mutations, similar to those in hereditary papillary renal carcinoma, confer oncogenic properties.
  • To assess the in vivo tumorigenicity and metastatic potential of cells expressing altered Ron.

Main Methods:

  • Expression of wild-type and mutant mouse Ron in NIH3T3 cells.
  • Analysis of cellular phenotype, proliferation, and Ron phosphorylation.
  • In vivo assessment of tumor formation and experimental metastasis models.

Main Results:

  • Cells expressing wild-type or mutated Ron exhibited a transformed phenotype and increased proliferation.
  • Constitutive phosphorylation of Ron was observed in transformed cell lines.
  • Cells expressing wild-type and mutated Ron were highly tumorigenic in vivo, with some forming aggressive lung tumors.

Conclusions:

  • Ron functions as an aggressive oncogene when overexpressed or activated by mutation.
  • Mutations in Ron can drive tumor formation and metastasis, similar to Met.
  • Ron represents a potential therapeutic target in cancer treatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: